Tirzepatide in Hispanic/Latino Patients With Type 2 Diabetes: A Subgroup Analysis of the SURPASS Program.

MLA

Frías, Juan Pablo, et al. “Tirzepatide in Hispanic/Latino Patients With Type 2 Diabetes: A Subgroup Analysis of the SURPASS Program.” Journal of Clinical Endocrinology & Metabolism, vol. 109, no. 2, Feb. 2024, pp. 557–68. EBSCOhost, https://doi.org/10.1210/clinem/dgad495.

APA

Frías, J. P., Galindo, R. J., Wang, H., Malik, R. E., Chivukula, K. K., & Maldonado, J. M. (2024). Tirzepatide in Hispanic/Latino Patients With Type 2 Diabetes: A Subgroup Analysis of the SURPASS Program. Journal of Clinical Endocrinology & Metabolism, 109(2), 557–568. https://doi.org/10.1210/clinem/dgad495

Chicago

Frías, Juan Pablo, Rodolfo J Galindo, Hui Wang, Raleigh E Malik, K Karthik Chivukula, and Juan M Maldonado. 2024. “Tirzepatide in Hispanic/Latino Patients With Type 2 Diabetes: A Subgroup Analysis of the SURPASS Program.” Journal of Clinical Endocrinology & Metabolism 109 (2): 557–68. doi:10.1210/clinem/dgad495.